These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 4116378)

  • 1. Identification of two determinants included in "antigen" HL-A-10 (TO 31 and TO 40) and of a new family of cross-reacting specificities (HL-A1,11,TO 30,31,40).
    Richiardi P; Curtoni ES; Piazza A; Mattiuz PL
    Tissue Antigens; 1971; 1(4):162-70. PubMed ID: 4116378
    [No Abstract]   [Full Text] [Related]  

  • 2. Cross-reactions of HL-A antibodies. V. Relationship between the human HL-A11 and chimpanzee ChW-11 specificities.
    Dorf ME; Toth EK; Balner H
    Tissue Antigens; 1972; 2(6):461-72. PubMed ID: 4119293
    [No Abstract]   [Full Text] [Related]  

  • 3. Studies on cross reactive HL-A antibodies by elution with platelets.
    Mueller-Eckhardt C; Heinrich D; Rothenberg V
    Tissue Antigens; 1972; 2(6):436-46. PubMed ID: 4265176
    [No Abstract]   [Full Text] [Related]  

  • 4. Importance of histocompatibility in platelet transfusion therapy.
    Yankee RA
    Vox Sang; 1971 May; 20(5):419-26. PubMed ID: 4106552
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of cross reactions on HL-A antigen immunogenicity.
    Colombani J; Colombani M; Degos L; Terrier E; Gaudy Y; Dastot H
    Tissue Antigens; 1974; 4(2):136-45. PubMed ID: 4600426
    [No Abstract]   [Full Text] [Related]  

  • 6. Blood platelets in HL-A serology.
    Colombani J
    Transplant Proc; 1971 Jun; 3(2):1078-87. PubMed ID: 5134491
    [No Abstract]   [Full Text] [Related]  

  • 7. Linear and nonlinear HL-A9 subdivisions generated by serial dilution.
    Waters H; Walford RL
    Immunol Commun; 1973; 2(1):57-64. PubMed ID: 4139105
    [No Abstract]   [Full Text] [Related]  

  • 8. Cross-reactions of HL-A antibodies. IV. Absorptions and elutions with primate platelets.
    Dorf ME; Eguro S; Amos DB
    Transplant Proc; 1972 Mar; 4(1):71-5. PubMed ID: 4110960
    [No Abstract]   [Full Text] [Related]  

  • 9. Cross-reactivity in the HL-A system.
    Mittal KK; Terasaki PI
    Tissue Antigens; 1972; 2(2):94-104. PubMed ID: 4116732
    [No Abstract]   [Full Text] [Related]  

  • 10. The preparation and purification of HL-A monospecific antigens using platelets and various lymphoid sources.
    Voigtmann R; Uhlenbruck G; Pardoe GI; Rogers K
    Eur J Immunol; 1974 Oct; 4(10):674-8. PubMed ID: 4139020
    [No Abstract]   [Full Text] [Related]  

  • 11. Serological and genetic studies of the HL-A system. Results of host immunization within haplo-identical donor-recipient combinations.
    Legrand L; Dausset J; Rapaport FT
    Transfusion; 1971; 11(5):233-50. PubMed ID: 4106583
    [No Abstract]   [Full Text] [Related]  

  • 12. HL-A matching in thrombocyte and leukocyte transfusions.
    Matej H; Olearczyk J; Partyka T; Kotlarek-Haus S; Stawarz M; Dzierzkowa-Borodej W
    Arch Immunol Ther Exp (Warsz); 1975; 23(2):181-7. PubMed ID: 807177
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Mo 91 antigen, an allele at the first HL-A locus.
    Seignalet J
    Tissue Antigens; 1972; 2(6):454-60. PubMed ID: 4119292
    [No Abstract]   [Full Text] [Related]  

  • 14. Transfer of HL-A antibodies from the mother to the child. Complement of information.
    Tongio MM; Mayer S; Lebec A
    Transplantation; 1975 Aug; 20(2):163-6. PubMed ID: 1101481
    [No Abstract]   [Full Text] [Related]  

  • 15. Changeable lymphocytotoxic antibody activity in patients with cervical carcinoma.
    Vos GH; Hammond MG; Marescotti G
    Vox Sang; 1975; 28(4):285-92. PubMed ID: 47664
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cross reactions of HL-A antibodies. I. Characterization by absorption and elution.
    Yunis EJ; Amos DB; Eguro SY; Dorf ME
    Transplantation; 1972 Oct; 14(4):474-9. PubMed ID: 4566162
    [No Abstract]   [Full Text] [Related]  

  • 17. The specificity of leukocyte and platelet alloantibodies in sera of patients with nonhemolytic transfusion reactions. Absorptions and elution studies.
    Heinrich D; Mueller-Eckhardt C; Stier W
    Vox Sang; 1973 Nov; 25(5):442-56. PubMed ID: 4587912
    [No Abstract]   [Full Text] [Related]  

  • 18. Lymphocyte antibody lymphocytolytic interaction (LALI) with special emphasis on HL-A.
    Trinchieri G; De Marchi M; Mayr W; Savi M; Ceppellini R
    Transplant Proc; 1973 Dec; 5(4):1631-49. PubMed ID: 4130071
    [No Abstract]   [Full Text] [Related]  

  • 19. Typing for the MLC determinants and its possible impact on Europdonor.
    van Rood JJ; van Leeuwen A; van den Tweel JG; Blussé van Oud Alblas A; Keuning JJ; Eernisse JG
    Transplant Proc; 1974 Dec; 6(4):411-5. PubMed ID: 4140594
    [No Abstract]   [Full Text] [Related]  

  • 20. [Anti HL-A transfusion immunization after extracorporeal circulation].
    Colombani J; Colombani M; Dastot H; Terrier E; Baillet M; Jaulmes B
    Nouv Rev Fr Hematol; 1972; 12(2):201-16. PubMed ID: 4264614
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.